Kozlova I. Peculiarities of metabolic syndrome complicated by the chronic kidney disease: possibilities of drug therapy correction

Українська версія

Thesis for the degree of Candidate of Sciences (CSc)

State registration number

0409U004753

Thesis Registration Form

0409U004753.pdf

Applicant for

Specialization

  • 14.01.02 - Внутрішні хвороби

09-10-2009

Specialized Academic Board

Д 20.601.01

Ivano-Frankivsk national medical university

Essay

Object - clinical-biochemical features of 127 patients with metabolic syndrome, complicated by chronic kidney disease, and morpfological features of kidney of 124 autopsy and 40 rats. The purpose - prove expediency of application enalapryl and losartan at a metabolic syndrome, novelty - components of syndrome in different degree influence expression cardiovascular risk and of kidney's injury, used of enalapryl and losartan in medical complex reduces cardiovascular risk and formation of kidney's pathology, results are introduced in educational and medical process. Branch - medicine.

Read more

Files

Dis1.doc

aref.doc

aref.doc

Similar theses

0524U000156

Iryna M. Halabitska

Optimization of diagnostics of osteoarthritis with pancreatic functional insufficiency in comorbidity conditions: clinical and metabolic features and development predictors

0424U000059

Khrystyna Mykolaivna M. Fedorovych

Clinical and laboratory features of the cardiovascular status of patients with rheumatoid arthritis and optimization of the principles of its correction.

0523U100054

Strilchuk Larysa Mykolaivna

Autonomic viscero-visceral cardioneuropathy in patients with biliary disorders: prevalence, mechanisms, pathogenesis, clinical polymorphism, and treatment approaches

0523U100045

Didenko Volodymyr Izotovych

Chronic diffuse liver diseases: etiological, structural and clinical-biochemical aspects of the formation of fibrous changes (clinical-experimental study)

0422U100009

Bazhenova Nataliia Mykhailivna

The state of platelet-plasma hemostasis in patients with arterial hypertension in combination with obesity and nonalcoholic fatty liver disease